Sermonix Pharmaceuticals Announces Poster Presentation on Phase 1 Ethnobridging Study of Lasofoxifene at the 12th AACR-JCA Joint Conference: Breakthroughs in Cancer Research — Translating Knowledge Into Practice

Author's Avatar
Dec 08, 2022

Study evaluated safety, tolerability and pharmacokinetics of oral lasofoxifene in healthy Japanese and Caucasian women